Christopher G. Hubert,Patrick J. Paddison,James M. Olson,Robert K. Bradley
申请号：
US14381965
公开号：
US20150025017A1
申请日:
2013.02.28
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present disclosure provides compositions and methods for treating cellular hyperproliferative disorders with a PHF5α inhibitor, such as siRNA, shRNA, antisense oligonucleotides, or pharmaceutical compounds. Exemplary cellular hyperproliferative disorders that can be treated with the PHF5α antagonists of the present disclosure include cancers, such as gliomas, adenocarcinomas, cervical cancer or prostate cancer.
